{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:02:45Z","timestamp":1783036965971,"version":"3.54.6"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,18]]},"DOI":"10.1093\/cid\/ciy019","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T12:30:38Z","timestamp":1515587438000},"page":"80-88","source":"Crossref","is-referenced-by-count":38,"title":["Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy"],"prefix":"10.1093","volume":"67","author":[{"given":"Elizabeth A","family":"Eckman","sequence":"first","affiliation":[{"name":"Atlantic Health System, Morristown"},{"name":"Biomedical Research Institute of New Jersey, Cedar Knolls"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pacheco-Quinto","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute of New Jersey, Cedar Knolls"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee R","family":"Herdt","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute of New Jersey, Cedar Knolls"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Halperin","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Overlook Medical Center, Atlantic Health System, Summit, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"key\n\t\t\t\t20180618193547_CIT0001","first-page":"1","article-title":"Surveillance for Lyme disease\u2014United States, 1992\u20132006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"key\n\t\t\t\t20180618193547_CIT0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/JCM.28.3.473-479.1990","article-title":"Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis","volume":"28","author":"Karlsson","year":"1990","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180618193547_CIT0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0004","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in Lyme neuroborreliosis","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180618193547_CIT0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/WNL.42.1.43","article-title":"Neuroactive kynurenines in Lyme borreliosis","volume":"42","author":"Halperin","year":"1992","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0006","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1086\/648091","article-title":"Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii","volume":"200","author":"Strle","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180618193547_CIT0007","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000171349.06645.79","article-title":"The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis","volume":"65","author":"Rupprecht","year":"2005","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-13-2","article-title":"Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection","volume":"13","author":"Bremell","year":"2013","journal-title":"BMC Neurol"},{"key":"key\n\t\t\t\t20180618193547_CIT0009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-6-42","article-title":"The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis","volume":"6","author":"Rupprecht","year":"2009","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180618193547_CIT0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1742-2094-8-36","article-title":"Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study","volume":"8","author":"Henningsson","year":"2011","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180618193547_CIT0011","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/art.37875","article-title":"Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A","volume":"65","author":"Codolo","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180618193547_CIT0012","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cid\/cix002","article-title":"T-elper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618193547_CIT0013","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cid\/cit735","article-title":"Elevated levels of IL-23 in a subset of patients with post-Lyme disease symptoms following erythema migrans","volume":"58","author":"Strle","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618193547_CIT0014","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.39.6.753","article-title":"Lyme neuroborreliosis: central nervous system manifestations","volume":"39","author":"Halperin","year":"1989","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0015","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.41.10.1571","article-title":"Central nervous system abnormalities in Lyme neuroborreliosis","volume":"41","author":"Halperin","year":"1991","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0016","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apm.12596","article-title":"Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis","volume":"124","author":"Henningsson","year":"2016","journal-title":"APMIS"},{"key":"key\n\t\t\t\t20180618193547_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hyt\u00f6nen","year":"2014","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180618193547_CIT0018","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00415-008-0785-y","article-title":"CSF B\u2013lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis","volume":"255","author":"Lj\u00f8stad","year":"2008","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180618193547_CIT0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2013.11.002","article-title":"Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis","volume":"157","author":"Moniuszko","year":"2014","journal-title":"Immunol Lett"},{"key":"key\n\t\t\t\t20180618193547_CIT0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jns.2016.05.059","article-title":"Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections","volume":"368","author":"P\u00edcha","year":"2016","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180618193547_CIT0021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-017-0948-9","article-title":"Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study","volume":"14","author":"Remy","year":"2017","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180618193547_CIT0022","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","article-title":"Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis","volume":"62","author":"Tjernberg","year":"2011","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180618193547_CIT0024","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"van Burgel","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180618193547_CIT0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0404.2010.01477.x","article-title":"CXCL13 chemokine in pediatric and adult neuroborreliosis","volume":"124","author":"Wutte","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20180618193547_CIT0026","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni.2431","article-title":"Cytokines of the \u03b3c family control CD4+ T cell differentiation and function","volume":"13","author":"Yamane","year":"2012","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180618193547_CIT0027","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjmed.2013.02.014","article-title":"Treatment trials for post-Lyme disease symptoms revisited","volume":"126","author":"Klempner","year":"2013","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180618193547_CIT0028","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180618193547_CIT0029","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618193547_CIT0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"key\n\t\t\t\t20180618193547_CIT0031","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","article-title":"CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis","volume":"37","author":"Marra","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180618193547_CIT0032","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","article-title":"CXCL13 and CXCL12 in central nervous system lymphoma patients","volume":"15","author":"Fischer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180618193547_CIT0033","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0b013e3181c5b457","article-title":"Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS","volume":"73","author":"Sellebjerg","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180618193547_CIT0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t20180618193547_CIT0035","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00415-015-7891-4","article-title":"Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis","volume":"262","author":"Dersch","year":"2015","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180618193547_CIT0036","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cid\/civ638","article-title":"Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome","volume":"61","author":"Tang","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618193547_CIT0037","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t20180618193547_CIT0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-10-30","article-title":"Th1 and Th17 but no Th2-related cytokine spectrum in the cerebrospinal fluid of children with Borrelia-related facial nerve palsy","volume":"10","author":"Liba","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"key\n\t\t\t\t20180618193547_CIT0039","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.06.007","article-title":"Interleukin-7: fuel for the autoimmune attack","volume":"45","author":"Dooms","year":"2013","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t20180618193547_CIT0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","article-title":"IL-7 in human health and disease","volume":"24","author":"Lundstr\u00f6m","year":"2012","journal-title":"Semin Immunol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/1\/80\/25048051\/ciy019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T18:17:11Z","timestamp":1751221031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/1\/80\/4797597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,11]]},"published-print":{"date-parts":[[2018,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy019","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,1]]},"published":{"date-parts":[[2018,1,11]]}}}